DrugDashboards

Mucinex D

Guaifenesin and Pseudoephedrine Hydrochloride · GUAIFENESIN 600 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 60 mg/1 · Tablet, Extended Release · Oral · Reckitt Benckiser LLC

NDC 63824-0057-18 · 1 BLISTER PACK in 1 CARTON / 18 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · NDA · View full market →

The short version

9 companies supply this market — a reasonable cushion if one runs into trouble. The price has held steady around $0.6808 per unit over the past year.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.25$0.5$0.75Nov 2013Jun 2024$0.6808
41 price points · per · last surveyed Jun 1, 2024Source: CMS NADAC

Estimated fill cost

Estimated WAC per estimate
≈ $0.702
No Texas or California filing exists for this NDC — this figure is derived, not filed.

This is an ESTIMATE derived from NADAC, not a filed or published price: pharmacies typically acquire brand drugs at roughly 2–4% below list, so list ≈ NADAC ÷ 0.97. Shown only because no state transparency filing exists for this NDC.

Medicaid spend (2024)

$23,145
1,115 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.2%chance of a new FDA shortage posting for guaifenesin and pseudoephedrine hydrochloride (oral solid) in the next 90 days

price up 24% YoY · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
NDA021585
TE code
—
Approval date
Jun 22, 2004
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Guaifenesin and Pseudoephedrine Hydrochloride (Tablet, Extended Release)

LabelerStrengthFirst seenLast seen
CVS PharmacyGUAIFENESIN 1200 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg/1Jul 15, 2026Sep 2, 2026
CVS Pharmacy, Inc.GUAIFENESIN 600 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 60 mg/1Jul 15, 2026Sep 2, 2026
Publix Super Markets, IncGUAIFENESIN 600 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 60 mg/1Jul 15, 2026Sep 2, 2026
Reckitt Benckiser LLCGUAIFENESIN 600 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 60 mg/1Jul 15, 2026Sep 2, 2026
Reckitt Benckiser LLCGUAIFENESIN 1200 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg/1Jul 15, 2026Sep 2, 2026
Rugby Laboratories, Inc.GUAIFENESIN 600 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 60 mg/1Jul 15, 2026Sep 2, 2026
Strategic Sourcing Services LlcGUAIFENESIN 600 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 60 mg/1Jul 15, 2026Sep 2, 2026
Walgreen CompanyGUAIFENESIN 600 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 60 mg/1Jul 15, 2026Sep 2, 2026
Walgreen CompanyGUAIFENESIN 600 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 60 mg/1Jul 15, 2026Sep 2, 2026
A-S Medication SolutionsGUAIFENESIN 600 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 60 mg/1Jul 15, 2026Aug 31, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Mucinex D — NDC 63824-0057-18," retrieved September 3, 2026, https://drugdashboards.com/drug/63824005718.

Free to cite with attribution — see how the data is put together.